Web24 sept. 2024 · Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies, today announced the completion of its business WebAcum 2 zile · The Trade: Jasper Therapeutics, Inc. (NASDAQ:JSPR) 10% owner Gary Rieschel acquired a total 2,666,666 shares an average price of $1.50. To acquire these …
Jasper Therapeutics Appoints David Hinds as Senior Vice …
Web14 apr. 2024 · February 18, 2024 Healthcare Highlights: Solomon Partners Healthcare Tech Group Year in Review Now Available. General Catalyst-backed Ro announces $150 million funding round. F-Prime Capital-backed Equip announces $58 million Series B. Andreessen Horowitz-backed Memora Health announces $40 million funding round. Web10 apr. 2024 · Jasper Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.6200 … curious mod minecraft
Jasper Therapeutics, Inc. ernennt David Hinds zum Senior Vice …
Web27 feb. 2024 · In the last 3 months, 7 analysts have offered 12-month price targets for Jasper Therapeutics. The company has an average price target of $5.77 with a high of … Web13 apr. 2024 · REDWOOD CITY, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria, lower to intermediate risk … Web12 apr. 2024 · In addition, Jasper Therapeutics Inc. saw 205.45% in overturn over a single year, with a tendency to cut further gains. Insider Trading. Reports are indicating that … easy heart knitting pattern